Why Illumina Stock Is Sinking Today
Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time, the S 500 had slid by 0.9% and the Nasdaq Composite was down 1.4%.
Illumina, a biotech company that develops and manufactures genetic testing systems, reported disappointing fourth-quarter numbers after the closing bell Thursday.
Illumina's revenue has stagnated or declined for several years now, and its total sales for 2024 were $4.3 billion, down from 2023's $4.5 billion. However, its bottom line was positive for the second quarter in a row in Q4, and its earnings of $0.95 per share beat expectations of $0.91 per share.
Source Fool.com
Illumina Inc. Aktie
127,10 €
-3,10 %
Bei der Aktie stehen derzeit 16 Buy-Einschätzungen 6 Sell-Einschätzungen gegenüber. Das Sentiment ist also durchaus positiv.
Allerdings ergibt sich ein Potenzial von -5.59% für Illumina Inc., da das Kursziel von 120 € unter dem aktuellen Kurs von 127.1 € liegt.
